Cardinal Health, Inc.

NYSE:CAH Stock Report

Market Cap: US$28.8b

Cardinal Health Past Earnings Performance

Past criteria checks 5/6

Cardinal Health has been growing earnings at an average annual rate of 51.3%, while the Healthcare industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 9.5% per year.

Key information

51.3%

Earnings growth rate

51.4%

EPS growth rate

Healthcare Industry Growth8.5%
Revenue growth rate9.5%
Return on equityn/a
Net Margin0.6%
Next Earnings Update30 Jan 2025

Recent past performance updates

Recent updates

Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.5056

Dec 07
Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.5056

Cardinal Health (NYSE:CAH) Is Due To Pay A Dividend Of $0.5056

Nov 23
Cardinal Health (NYSE:CAH) Is Due To Pay A Dividend Of $0.5056

Cardinal Health (NYSE:CAH) Has Affirmed Its Dividend Of $0.5056

Nov 09
Cardinal Health (NYSE:CAH) Has Affirmed Its Dividend Of $0.5056

Results: Cardinal Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Nov 05
Results: Cardinal Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Cardinal Health Q1 Earnings: Margins Signal More Upside

Nov 04

Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.5056

Sep 24
Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.5056

Here's Why We Think Cardinal Health (NYSE:CAH) Is Well Worth Watching

Sep 17
Here's Why We Think Cardinal Health (NYSE:CAH) Is Well Worth Watching

Cardinal Health (NYSE:CAH) Is Due To Pay A Dividend Of $0.5056

Aug 19
Cardinal Health (NYSE:CAH) Is Due To Pay A Dividend Of $0.5056

Cardinal Health: Growth Headwinds Ahead

Aug 01

Cardinal Health: Growing Into The Valuation

Jul 02

Cardinal Health (NYSE:CAH) Has Announced That It Will Be Increasing Its Dividend To $0.5056

Jun 11
Cardinal Health (NYSE:CAH) Has Announced That It Will Be Increasing Its Dividend To $0.5056

Cardinal Health's Valuation Makes The Name Unattractive

May 26

Cardinal Health Q3 Earnings: Undervalued On Strong Guidance

May 03

Potential Upside For Cardinal Health, Inc. (NYSE:CAH) Not Without Risk

Apr 14
Potential Upside For Cardinal Health, Inc. (NYSE:CAH) Not Without Risk

Is Cardinal Health, Inc. (NYSE:CAH) Trading At A 50% Discount?

Mar 09
Is Cardinal Health, Inc. (NYSE:CAH) Trading At A 50% Discount?

Cardinal Health: Continued Business Growth And Huge Medical Supplies Market Penetration

Feb 20

Cardinal Health, Inc. (NYSE:CAH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think

Feb 03
Cardinal Health, Inc. (NYSE:CAH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think

Cardinal Health Is Setting Up For A Great 2024

Dec 21

Cardinal Health: A Revenue Growth Gem Plagued By Symptoms Of Negative Equity

Oct 13

Cardinal Health: Better EPS Growth Clarity, Buying Back Shares, A Buy On Valuation

Aug 07

Cardinal Health: Not A Long-Term Investment

May 24

Cardinal Health: Downgrading Due To Absence Of Safety Margin (Rating Downgrade)

Feb 21

Cardinal Health declares $0.4957 dividend

Feb 10

Cardinal Health FQ2 2023 Earnings Preview

Feb 01

Cardinal Health partners with Palantir for data-driven supply chain support

Jan 26

Cardinal Health Is A Tempting Healthcare Income Play

Dec 28

Aaron Alt is the new finance chief at Cardinal health

Dec 19

Revenue & Expenses Breakdown

How Cardinal Health makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NYSE:CAH Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24224,4541,2805,0910
30 Jun 24226,8278525,0000
31 Mar 24220,4266044,9840
31 Dec 23216,0026914,8810
30 Sep 23210,0262084,7890
30 Jun 23204,9793304,8000
31 Mar 23198,6624634,7220
31 Dec 22193,011-1,2734,6800
30 Sep 22186,999-1,0944,6400
30 Jun 22181,326-9384,5120
31 Mar 22176,847-9554,5310
31 Dec 21171,2865554,5140
30 Sep 21167,3701,1354,5100
30 Jun 21162,4676114,5330
31 Mar 21156,5701,1514,5410
31 Dec 20156,4521,3824,5860
30 Sep 20154,6469734,6020
30 Jun 20152,922-3,6964,5720
31 Mar 20153,586-4,1584,6000
31 Dec 19149,657-4,2124,5310
30 Sep 19147,662-4,1524,4320
30 Jun 19145,5341,3634,4800
31 Mar 19143,53034,5860
31 Dec 18141,935-394,6220
30 Sep 18139,3817344,6890
30 Jun 18136,8092564,5960
31 Mar 18134,4261,6964,3080
31 Dec 17132,6141,8234,1370
30 Sep 17130,5781,0943,9170
30 Jun 17129,9761,2883,7750
31 Mar 17128,3941,3463,7620
31 Dec 16127,2361,3513,7150
30 Sep 16125,5301,3533,7260
30 Jun 16121,5461,4273,6480
31 Mar 16117,7101,3873,5250
31 Dec 15112,4231,3663,4140
30 Sep 15106,5161,3293,3070
30 Jun 15102,5311,2123,2400
31 Mar 1597,8771,1543,1880
31 Dec 1493,9281,1043,1210
30 Sep 1490,6311,0893,0710
30 Jun 1491,0841,1633,0280
31 Mar 1493,6103433,0090
31 Dec 1396,7353742,9840

Quality Earnings: CAH has high quality earnings.

Growing Profit Margin: CAH's current net profit margins (0.6%) are higher than last year (0.1%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: CAH has become profitable over the past 5 years, growing earnings by 51.3% per year.

Accelerating Growth: CAH's earnings growth over the past year (515.4%) exceeds its 5-year average (51.3% per year).

Earnings vs Industry: CAH earnings growth over the past year (515.4%) exceeded the Healthcare industry 10.4%.

Return on Equity

High ROE: CAH's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 23:26
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cardinal Health, Inc. is covered by 40 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Gregory BolanAvondale Partners
Eric ColdwellBaird